Iron-deficiency anemia.

  title={Iron-deficiency anemia.},
  author={Clara Camaschella},
  journal={The New England journal of medicine},
  volume={372 19},
  • C. Camaschella
  • Published 6 May 2015
  • Medicine
  • The New England journal of medicine
Iron-deficiency anemia is the most common form of anemia in the world. This article reviews the global nature of the disease, iron homeostasis in normal and iron-deficient states, clinical findings, treatment, and causes of iron-resistant iron deficiency. 

Figures and Tables from this paper

Iron Metabolism and Iron Deficiency Anemia

This chapter discusses normal iron metabolism, etiopathogenesis, and laboratory tests along with prevention and treatment of iron deficiency anemia along with functional iron deficiency and iron deficiencyAnemia coexistent with thalassemia trait.

The Evidence-Based Evaluation of Iron Deficiency Anemia.

Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials

The effectiveness of oral iron replacement is compromised by lack of absorption, gastrointestinal perturbation, and non-adherence to treatment estimated to range from 10% at day 14 of therapy to 32% after two weeks.

How I approach iron deficiency with and without anemia

Improved understanding of iron homeostasis, including the effects of the regulatory hormone hepcidin, recent adult and pediatric clinical trial data, as well as the availability of safer formulations of intravenous iron, have resulted in additional considerations when making treatment recommendations in patients with iron deficiency anemia.

Iron-Deficiency Anemia

Age, tolerance, preferred route of administration, and severity of anemia are some of the patient’s characteristics which require an individualized approach, but diagnosis should prompt further investigation to establish the cause for potential reversal.

Anemia in celiac disease is multifactorial in etiology: A prospective study from India

This work aimed to study the prevalence and etiology of anemia in CD in a north Indian population with a focus on iron deficiency anemia.

Anemia of Inflammation with An Emphasis on Chronic Kidney Disease

Iron is vital for a vast variety of cellular processes and its homeostasis is strictly controlled and regulated. Nevertheless, disorders of iron metabolism are diverse and can be caused by

The role of iron repletion in adult iron deficiency anemia and other diseases

A framework to diagnose, manage, and treat patients presenting with IDA is provided and other conditions that benefit from iron supplementation are discussed.



Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)

It is shown that iron deficiency anemia refractory to oral iron therapy can be caused by germline mutations in TMPRSS6, which encodes a type II transmembrane serine protease produced by the liver that regulates the expression of the systemic iron regulatory hormone hepcidin.

Anemia of chronic disease.

Advances in knowledge of the causes and management of the anemia of chronic disease are discussed.

Diagnosis and management of iron deficiency anemia.

Hematologic parameters predicting a response to oral iron therapy in chronic inflammation

In anemic patients with chronic inflammatory conditions, the assessment of iron status and the selection of those who may benefit from iron therapy frequently presents diagnostic

The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method

Iron deficiency is a common and undertreated problem in inflammatory bowel disease (IBD) and it is important to select patients suitable for treatment with iron antagonists for IBD.

Guideline for the laboratory diagnosis of functional iron deficiency

One form of FID, found in some subjects treated with erythropoiesis-stimulating agents (ESAs), has been the subject of numerous studies following the widespread use of these agents, especially in subjects with chronic kidney disease (CKD).

Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches

New data on the importance of iron deficiency in HF have become available, and a number of studies with intravenous iron have shown promising results, and this treatment approach is likely to become an attractive option for patients with HF and iron deficiency, both with and without anemia.

Iron refractory iron deficiency anemia

In patients with Matriptase-2 deficiency, serum hepcidin is inappropriately high for the low iron status and accounts for the absent/delayed response to oral iron treatment, a challenge for the clinicians and pediatricians is recognition of the disorder among iron deficiency and other microcytic anemias commonly found in pediatric patients.

Anaemia: FIND-CKD: intravenous iron in predialysis CKD

Intravenous FCM treatment to achieve a higher serum ferritin target improved patient haemoglobin levels and reduced initiation of other anaemia treatments.

A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia

  • Jane E. OnkenDavid B. Bregman L. Goodnough
  • Medicine
  • 2014
Many patients receiving oral iron for iron deficiency anemia (IDA) cannot tolerate or fail to respond to therapy, and existing intravenous (IV) iron formulations often require repeated